A few days ago I talked about my experience of publishing preprints with PeerJ and why I believe in this type of scientific dissemination. Now, I will present another new way to present the scientific results: the publication of posters and slides in the F1000Research. This service is an open access platform for the publication of results from scientists in the field of biological and health sciences . Its main uniqueness is the supposed non-interference of an editorial body in the publications. The F1000Research staff states that it is not a journal, or a newspaper. They use the term "publishing platform" to convey this concept, but still leave it vague enough to allow for varying interpretations. The publications go through a brief editorial evaluation and are published quickly (sometimes in a few hours!) after submission. The initial evaluation is mandatory and serves to filter cases of blatant deviation from editorial rules. There is no pre-publication peer review. Despite this, the F1000Research insists that its publications "are not preprints". In fact, once you publish your material there, you can no longer edit it, unlike PeerJ Preprints, where this functionality still persists.
In the case of scientific articles, a "post-publication" peer review may occur and is identified. The stories of F1000Research experiences are varied, ranging from those who worship it, to those who will never submit again. Librarian Jeffrey Beall has cited F1000Research in his Scholarly Open Access blog for accepting a paper possibly in the frontier between science and fraud ("fringe paper"). Such an occurrence should not, in fact, denigrate that publishing platform, since its policy is to publish first and then revise. Checking the publication, we can see that it received 1 approval and 2 rejections, leading to conclude that Beall's assessment may be correct: it can be a "fringe paper." Due to the nature of the F1000Research editorial process, however, this does not mean that this platform has lower quality. Articles of questionable quality assessed a posteriori have also been published in many traditional journals and the refutation of their claims is part of the development of science as a whole.
I especially like the proposal to publish all the posters presented at congresses in a repository. At the moment, this F1000Research service is free and without limits. Posters may be published in any language, but metadata should be described in English. After submission, an evaluation is performed for editorial homogeneity, markers are assigned and the poster is published (publicly available, with DOI and can be cited). This type of proposal has the advantage of promoting the dissemination of data that is still preliminary, but which may be useful. In addition, it can help reduce publication bias by encouraging the publication of negative data that, after presentation at events, is rarely published in conventional journals. Posters published on F1000Research are not indexed on popular platforms such as Google Scholar.
The submission process was very simple and fast. There is the option to add a poster summary, plus the title and keywords. It also tells you where and when the work was presented. The time between the submission and its approval varied, in my case, from 6 to 60 hours, or close to that. None of my submissions were rejected, but some English summaries (metadata) were truncated, usually leaving the introduction and conclusion and deleting the rest. Perhaps it was due to problems in the English language, but I believe that the staff of F1000Research has no homogeneity of judgment at this point, because all the abstracts were written in the same style and even with some similar texts, due to the proximity between the themes addressed. Even so, while some were published without any change, others were truncated in most of the text. Another thing I noticed was a variation on the assignment of markers, prerogative of the staff of F1000Research (in PeerJ, for example, the author chooses them). The choice of markers seemed, at times, random. In some of my posters, the neuro-oncology marker was correctly assigned. In five of them, an excessive number for those who propose a process with few errors, the marker chosen was "tumors of head and neck." This forced me to contact support twice, and in the second time there was a delay in response. Although it was a setback, it did not greatly diminish my impression on the quality of F1000Research.
All counted, I rate my experience with posting posters (and slides) in F1000Research on the positive side. This proposal is interesting and there are several alternative services coming up, like Figshare. I want to evaluate other repositories for posters, slides and other academic materials otherwise not published in conventional venues.
Link for the last poster I published in this platform: Descriptive longitudinal study of pediatric patients with primary brain tumors: establishment... - F1000Research
Assinar:
Postar comentários (Atom)
Clique aqui!
2015
A.C. Camargo
academic journals
acesso aberto
adverse drug reactions
alergia
alquilantes
alto custo
ambiente
ambientes virtuais
analgésicos
anomalias vasculares
anti-eméticos
anti-helmínticos
anti-histamínico
antianêmicos
antiangiogênico
anticâncer
anticoagulantes
antifúngicos
antiprotozoários
antivirais
artemisinina
arXiv
asma
asthma
atopia
atualização
aula
aulas
auto-arquivamento
avastin
avermectina
bevacizumab
biologicals
bioRxiv
Blogger
brain tumor
bundler
cancer
cancerologia pediátrica
Carlos Chagas
carne vermelha
cauterização
Ceará
CERN
child
chronic fatigue syndrome
ciência
ciência brasileira
ciências biológicas e da saúde
cientistas influentes
cirurgia
CLI
Command Line Tools
conselho internacional
crime virtual
CT scans
Curtis Harris
darbopoietina
dermatite
desenvolvedor
diabetes
dieta
disautonomia
dislipidemias
doença renal
doenças cardíacas
doenças parasitárias
dor
DPOC
eczema
editoras predatórias
efeitos adversos
eficácia
ensino e pesquisa
eritropoietina
erlotinib
ESA
escleroterapia
estatinas
esteróides
estilo de vida
exercícios
F1000Research
farmacogenética
farmacologia
fatores de crescimento
fibromialgia
Figshare
Fisiologia e Medicina
fitness
flu
FMJ
Fortaleza
fosfoetanolamina
fraude acadêmica
fraude eletrônica
genetics
GitHub
glioblastoma
gliomas
Google Books
Google mapas
gordos
green way
Harald zur Hausen
hemangiomas
hemophagocytic lymphohistiocytosis
High Sierra
homebrew
horário
imagem
immunology
imunossupressores
imunoterapia
infecção urinária
inibidores de ECA
inibidores tirosina-quinase
iniciação científica
insulina
irracionalismo
ivermectina
Jeffrey Beall
Jekyll
journal hijack
Lectures
lepra
leucemia
leukemia
linfangiomas
Mac OS
Mac OS X
macrophage activation syndrome
magrinhas
mal-formações
March for Science
Marcha pela Ciência
medicina personalizada
meta-análise
Milton Santos
modelos
monoclonais
monoclonal antibody
mortalidade
morte
mudança
Mulliken
neuro-oncologia
neuroblastoma
neurology
ngram viewer
Nobel
Nobel em Medicina ou Fisiologia
novas drogas
novos tratamentos
obesidade
ômega 3
open access
open science
OpenAIRE
osteoporose
Osvaldo Cruz
package installer
pediatria
pediatric cancer
pediatric tumors
pediatrics
peer review
PeerJ
personalized medicine
PET/CT
pharmacogenetics
pharmacological treatment
pharmacology
plágio
política de C&T
posters
postprints
predatory publishers
Preprints
pressão arterial
prevenção
progressista
projeto de pesquisa
propranolol
próstata
publicação
publicação científica
publicações
publication
pubmed
Python
python 2
python 3
quimioterapia
radiation
radioterapia
rapamycin
rbenv
recidiva
regressão espontânea
Regulação médica
repository
resposta
resultados
retrospectiva
revisão por pares
risco
Ruby
Satoshi Ömura
Scholarly Open Access
science
ScienceNOW
seguimento
selênio
self-archiving
sequestro de periódico científico
serotonina
SIDA
sildenafil
slides
sobrevida
sulfa
suplementos
survival
tacerva
targeted therapy
temozolamida
temozolomide
terapia alternativa
tireóide
tratamento
tuberculose
tumores cerebrais
tumores pediátricos
vaccine
vacina
venv
via dourada
via verde
virtualenv
virtualenvwrapper
vitamina E
vitaminas
William C. Campbell
Xcode
Youyou Tu
Zenodo
Postagens populares
-
Malformações linfáticas (ML), também conhecidas como linfangiomas, são anomalias vasculares congênitas incomuns, representando muitas vezes...
-
Os tumores cerebrais em crianças são raros - em Fortaleza, CE pouco mais de 1 criança em cada 100 mil vai ter um tumor cerebral, algo em tor...
-
A prestigiada revista Lancet Oncology publicou recentemente o resultado de um ensaio clínico fase II que avaliou um novo tratamento em paci...
-
Essa aula de atualização em gliomas de crianças e adolescentes foi apresentada em 15 de setembro de 2011, dois anos atrás, na Liga do Cânc...
-
Em junho de 2008, um grupo de dermatologistas franceses publicou uma carta no New England Journal of Medicine , um dos mais prestigiados jo...
Nenhum comentário:
Postar um comentário